Shandong Huihai Pharmaceutical & Chemical Co., Ltd. (hereinafter referred to as "Huihai company") was established in 2005. It is a wholly-owned subsidiary of Shandong Jincheng Pharmaceutical Co., Ltd. (Stock Code: 300233). It mainly focuses on the development and production of basic chemical raw materials and is a high-tech enterprise integrating R & D, production, sales and service. It covers an area of 270 mu, with more than 650 employees and a total investment of 600 million yuan. Huihai pharmaceutical currently has 9 workshops. Its leading products include nine conventional varieties such as acetonitrile, ethyl acetoacetate, tert butyl acetoacetate, aabi, DCC and triazine ring. The process technology is advanced and the quality is stable and reliable. The products are sold to Harbin Pharmaceutical Group, Zhuhai Federation, Qilu and other famous pharmaceutical factories in China, and exported to India, Belgium, Japan and other countries. The main products AABI, DCC and triazine ring account for more than 50% of the domestic and foreign market shares, It is a large production and scientific research base of cephalosporin pharmaceutical intermediates in the world. The products have established a modern, scientific and standardized management system. At present, the company has established three provincial-level R & D platforms, namely, Shandong Engineering Technology Research Center, Shandong enterprise technology center and Shandong "one enterprise one technology" R & D center, and four municipal R & D platforms, namely, Dongying technology innovation center, Dongying Key Laboratory, Dongying engineering laboratory and Dongying Industrial design center, which have laid a foundation for the continuous innovation and development of Huihai company. Since its establishment, the company has always put scientific and technological innovation in the first place and has established long-term and stable cooperative relations with Jinan University, Tianjin University, Dalian University of technology and other institutions of higher learning. The company invested 5.58 million yuan to build a new technology center building, covering an area of 3257 square meters, which is mainly used for research and development of new products and improvement of new processes. The development of the company is finally reflected by the brand "Huihai". With the strong support of governments at all levels, the connotation of enterprise culture, relying on excellent product quality, excellent production scale, improved industrial grade, optimized product structure and innovative management concept, Huihai pharmaceutical will certainly develop into a modern enterprise with great influence in the field of pharmaceutical chemical products and characteristic raw materials.